|28th February 2021||Karen L Daniel||183||Grant/award etc.||$74.03||$13,547.49|
|25th February 2021||Sandra L Fenwick||7,173||Exercise of derivative||$0.00|
|25th February 2021||Karen L Daniel||7,173||Exercise of derivative||$0.00|
|11th February 2021||Karen L Daniel||762||Grant/award etc.||$0.00|
|1st February 2021||Glen Tullman||164,931||Exercise of derivative||$5.26||$867,537.06|
|1st February 2021||Glen Tullman||164,931||Open or private sale||$262.61||$43,312,529.91|
|14th January 2021||Glen Tullman||164,931||Exercise of derivative||$5.26||$867,537.06|
|14th January 2021||Glen Tullman||164,931||Open or private sale||$225.12||$37,129,266.72|
|31st December 2020||Karen L Daniel||762||Grant/award etc.||$65.70||$50,063.40|
|8th December 2020||Hemant Taneja||4,900||Open or private sale||$197.39||$967,206.59|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 6/10.
Livongo Health, Inc. develops and operates a consumer digital health platform. It focuses on diabetes, hypertension, weight management, diabetes prevention, and behavioral health. The company was founded by Kimon Angelides and Glen E. Tullman on October 16, 2008.